Shifting corporate strategies on diversity, equity and inclusion, traditional journalists losing ground to influencers and ...

From Pfizer to AstraZeneca and the Omnicom-IPG Merger, the industry has seen a number of executive moves during this year.

The healthcare technology solutions firm is saying goodbye to CEO William J. Febbo, who is leaving the company effective ...

Big moments filled pharma marketing’s 2024. Pfizer made the leap into the Super Bowl, a number of campaigns won big in Cannes ...

The Biden administration hasn’t delivered on its goals of measuring the public health impact of abortion bans. Experts say it ...

The first procedure was listed as “colonoscopy and biopsy,” while the second was listed as “colonoscopy w/lesion removal.” ...

Nearly 70 government officials, farmers and farmworkers, and researchers with expertise in virology, pandemics and more weigh ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

Corcept’s first hypercortisolism awareness and screening campaign highlights the prevalence of what was long thought to be a very rare condition.

Although Novo underscored that patients in the trial achieved up to 22.7% of weight loss with CagriSema, analysts previously said they were hoping to see whether it would significantly beat Lilly’s ...

Data suggest a move away from compensation as the be-all and end-all for medical marketers. Is thriving at work the ‘new black’?

Anthony Olson was told that he’d die without the treatment and to ignore a negative biopsy. He’s one of many patients who may have received harmful or unnecessary treatments from Montana oncologist Dr ...